Oriola Oyj Series B
Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and resea… Read more
Oriola Oyj Series B (0NES) - Total Liabilities
Latest total liabilities as of March 2025: €830.90 Million EUR
Based on the latest financial reports, Oriola Oyj Series B (0NES) has total liabilities worth €830.90 Million EUR as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Oriola Oyj Series B - Total Liabilities Trend (2006–2024)
This chart illustrates how Oriola Oyj Series B's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Oriola Oyj Series B Competitors by Total Liabilities
The table below lists competitors of Oriola Oyj Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Elnusa Tbk
JK:ELSA
|
Indonesia | Rp5.60 Trillion |
|
Clearview Wealth Ltd
AU:CVW
|
Australia | AU$717.27 Million |
|
Sichuan Jinshi Technology Co Ltd Class A
SHE:002951
|
China | CN¥350.20 Million |
|
Feedback Technology
TWO:8091
|
Taiwan | NT$1.39 Billion |
|
Jash Engineering Limited
NSE:JASH
|
India | ₹3.27 Billion |
|
Hong Kong Television Network Ltd
PINK:HKTVY
|
USA | $1.29 Billion |
Liability Composition Analysis (2006–2024)
This chart breaks down Oriola Oyj Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.84 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 6.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.86 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Oriola Oyj Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Oriola Oyj Series B (2006–2024)
The table below shows the annual total liabilities of Oriola Oyj Series B from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €742.20 Million | -2.78% |
| 2023-12-31 | €763.40 Million | +3.82% |
| 2022-12-31 | €735.30 Million | -16.10% |
| 2021-12-31 | €876.40 Million | -12.01% |
| 2020-12-31 | €996.00 Million | +14.04% |
| 2019-12-31 | €873.40 Million | +17.05% |
| 2018-12-31 | €746.20 Million | +2.97% |
| 2017-12-31 | €724.70 Million | +0.62% |
| 2016-12-31 | €720.20 Million | -4.27% |
| 2015-12-31 | €752.30 Million | -1.07% |
| 2014-12-31 | €760.40 Million | -37.77% |
| 2013-12-31 | €1.22 Billion | +21.76% |
| 2012-12-31 | €1.00 Billion | +3.04% |
| 2011-12-31 | €974.00 Million | +15.97% |
| 2010-12-31 | €839.90 Million | +27.62% |
| 2009-12-31 | €658.10 Million | +8.76% |
| 2008-12-31 | €605.10 Million | +36.96% |
| 2007-12-31 | €441.80 Million | +5.34% |
| 2006-12-31 | €419.40 Million | -- |